Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Nov 15, 2026
TickeronGET DAILY SIGNALS
Ryan Specialty (RYAN) Climbs +23% Over 30 Days: Earnings and Buybacks Fuel the Rebound

Ryan Specialty (RYAN) Climbs +23% Over 30 Days: Earnings and Buybacks Fuel the Rebound

Key Takeaways

  • RYAN shares climbed roughly 23% over the last 30 days, rebounding from about $38.00 in mid-October to near $46.89.
  • Third-quarter 2026 results, reported in late October, showed total revenue of $790.0 million, up 4.7% year over year, with adjusted diluted EPS of $0.51.
  • Adjusted EPS beat analyst consensus estimates, while management maintained full-year organic revenue growth guidance toward the higher end of its mid-single-digit range.
  • Aggressive share repurchases — including $150 million in the third quarter — and a $0.13 quarterly dividend reinforced a shareholder-friendly capital-return strategy.
  • Over the last quarter, the stock is up about 9.5%, recovering after a September pullback that took shares toward the mid-$36 area.

Company Background and Market Position

RYAN is a leading international specialty insurance firm headquartered in Chicago and listed on the NYSE since its July 2021 initial public offering. Founded by insurance industry veteran Patrick G. Ryan, the company acts as a wholesale broker and managing underwriter, helping retail brokers, agents, and carriers place complex or hard-to-place risks.

The business operates across three principal specialties: Wholesale Brokerage, Binding Authority, and Underwriting Management. Its fee-based model, deep specialty expertise, and high producer retention have supported consistent organic growth, positioning the firm as one of the most prominent pure-play specialty intermediaries in the market. Investors follow RYAN closely for its growth trajectory, margin discipline, and capital-allocation decisions. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Stock Price Performance: Last 30 Days vs. the Quarter

Over the last 30 days, RYAN advanced from a closing price of $38.00 to approximately $46.89, a gain of about 23%. The move was concentrated in the second half of October and early November, as shares pushed through the $44 and $47 levels on above-average volume before consolidating near the high end of the range.

The longer three-month picture tells a more volatile story. Starting from roughly $42.82 in mid-August, the stock initially softened through September, touching a low near $36 in late September before a sharp recovery. As a result, the trailing-quarter gain of about 9.5% reflects a V-shaped rebound rather than a steady climb, with most of the appreciation occurring after third-quarter earnings were released.

What Drove the Stock Higher in the Last 30 Days

The primary catalyst was the company's third-quarter 2026 earnings report, released on October 29. Total revenue rose 4.7% to $790.0 million on organic growth of 4.0%, and adjusted diluted EPS increased 8.5% to $0.51, modestly ahead of analyst consensus. Net income climbed 40.6% to $88.0 million, while adjusted EBITDAC grew 3.8% to $244.4 million.

Investor sentiment also benefited from management's capital-return activity. The company repurchased 3.5 million shares for $150 million during the quarter and an additional 1.3 million shares for $50 million in October, bringing year-to-date capital returned to shareholders to roughly $573 million. The board also declared a $0.13 quarterly dividend.

Following the report, several analysts adjusted their views. Wells Fargo raised its price target to $46 with an Equal Weight rating, while firms including UBS and RBC maintained constructive ratings. Management's improved full-year margin guidance and progress on AI-related product initiatives — such as expanded capacity for GPU coverage — provided additional support to the narrative.

Performance Drivers Over the Last Quarter

Across the trailing three months, RYAN's performance reflected two distinct phases. In August and September, shares pulled back as investors weighed softer property pricing, heightened competition, and concerns about decelerating organic growth against a tough prior-year comparison. The stock bottomed near the mid-$36 area in late September.

The recovery that followed was driven by a combination of solid quarterly execution, consistent buybacks, and reassurance from management that organic growth guidance remained intact. New business wins, strong renewal retention, and expanding relationships in specialty and E&S markets helped offset pricing headwinds, restoring confidence and lifting the stock back toward the levels seen earlier in 2026.

What Investors Should Watch Next

Looking ahead, investors are likely to focus on pricing dynamics across property and casualty lines, where management has signaled continued property pricing declines and broader competitive pressure. Fourth-quarter results will test whether organic growth can hold toward the higher end of the mid-single-digit range amid these headwinds.

Other factors to monitor include the pace of share repurchases, progress on AI-related product launches, and any pickup in M&A activity that management has indicated could accelerate. Macroeconomic conditions, interest-rate movements, and shifts in the specialty and E&S insurance markets will also shape the outlook. As always, these considerations are informational and do not constitute investment advice. I’m watching this closely with help from Tickeron’s AI Trend Prediction Engine to stay on top of potential shifts.

Using Tickeron AI Trading Bots for Additional Perspective

In my research process, I frequently review Tickeron’s Trending AI Robots to see how automated strategies are positioning around names like this. The page offers a curated look at top-performing bots across various strategies and timeframes, which helps me understand algorithmic sentiment without replacing my own analysis. It serves as a useful supplement when evaluating how different models are navigating current market conditions for RYAN.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: RYAN

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


RYAN saw its Stochastic Oscillator leaves the overbought zone

The Stochastic Oscillator for RYAN moved out of overbought territory on November 13, 2026. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 61 similar instances where the indicator exited the overbought zone. In 46 of the 61 cases the stock moved lower. This puts the odds of a downward move at 75%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for RYAN moved out of overbought territory on November 09, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 34 similar instances where the indicator moved out of overbought territory. In 24 of the 34 cases, the stock moved lower in the following days. This puts the odds of a move lower at 71%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RYAN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 69%.

RYAN broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 13, 2026. You may want to consider a long position or call options on RYAN as a result. In 50 of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 60%.

RYAN moved above its 50-day moving average on October 16, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for RYAN crossed bullishly above the 50-day moving average on October 23, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 75%.

Following a +5.53% 3-day Advance, the price is estimated to grow further. Considering data from situations where RYAN advanced for three days, in 197 of 315 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.

The Aroon Indicator entered an Uptrend today. In 137 of 249 cases where RYAN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 55%.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. RYAN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 82 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RYAN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock better than average.

The Tickeron PE Growth Rating for this company is 88 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: RYAN's P/B Ratio (11.438) is slightly higher than the industry average of (2.681). RYAN has a moderately high P/E Ratio (61.192) as compared to the industry average of (19.012). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (8.322). Dividend Yield (0.011) settles around the average of (0.039) among similar stocks. P/S Ratio (1.707) is also within normal values, averaging (2.968).

Notable companies

The most notable companies in this group are eHealth (NASDAQ:EHTH).

Industry description

Insurance brokers sell, solicit, or negotiate insurance for compensation. General insurance brokers mostly cater to insurances on car, house etc. (versus life). Brokers are also often instrumental in helping small employers find health insurance, particularly in more competitive markets. Additionally, brokers may also provide risk assessments, insurance consulting services, insurance-related regulatory and legislative update services. Some of the major names in this industry include Marsh & McLennan Companies, Inc., Aon plc and Verisk Analytics Inc.

Market Cap

The average market capitalization across the Insurance Brokers/Services Industry is 15.27B. The market cap for tickers in the group ranges from 3.03K to 97.74B. MRSH holds the highest valuation in this group at 97.74B. The lowest valued company is CUII at 3.03K.

High and low price notable news

The average weekly price growth across all stocks in the Insurance Brokers/Services Industry was 1%. For the same Industry, the average monthly price growth was 12%, and the average quarterly price growth was 18%. AIFU experienced the highest price growth at 25%, while GSHD experienced the biggest fall at -17%.

Volume

The average weekly volume growth across all stocks in the Insurance Brokers/Services Industry was 233%. For the same stocks of the Industry, the average monthly volume growth was 288% and the average quarterly volume growth was 138%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 57
P/E Growth Rating: 71
Price Growth Rating: 49
SMR Rating: 72
Profit Risk Rating: 85
Seasonality Score: 2 (-100 ... +100)
AI Screener 3
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry InsuranceBrokersServices

Industry
N/A
Address
155 North Wacker Drive
Phone
+1 312 784-6001
Employees
6110
Web
https://www.ryanspecialty.com
Interact to see
Advertisement
The central price target used here is $400 , roughly 35% above Alphabet's latest verified closing price of $295.77 (November 13, 2026). This target is the arithmetic mean of verified analyst price targets reviewed, not a single analyst's forecast; independent data providers report comparable consensus averages in the high-$390s to low-$400s.
Upcoming catalysts: Integration of advertising into AI Overviews and Gemini conversations, the scaling of Gemini 3 and newer models across Search and Cloud, and the commercial ramp of the $32 billion Wiz cloud-security acquisition could all shape sentiment into 2026. Strategic positioning: Alphabet's vertically integrated artificial intelligence (AI) stack — from custom TPU (Tensor Processing Unit) chips to the Gemini models to Google Cloud — supports a durable, cost-advantaged position in the AI build-out.
The TETH exchange-traded fund (ETF) is the 21Shares Ethereum Staking ETF, a spot Ethereum fund listed on Cboe BZX, and it does not carry conventional analyst price targets. The $14 objective used here is a technical milestone discussed in public market commentary — roughly the zone where Ethereum could begin confirming a recovery — not an analyst consensus.
The central target of $6.70 is the arithmetic mean of seven recent, individually verified analyst price targets, rounded from $6.67. At a latest price near $3.70, reaching $6.70 would require roughly 81% upside — a very large move.
EUO is a leveraged inverse currency fund targeting -2x the daily performance of the euro versus the U.S. dollar, while XXX is a passive asset-allocation fund blending roughly 75% S&P 500 equities with 25% XRP exposure. The two funds are structurally unrelated: EUO is a tactical hedging and trading tool, whereas XXX is a diversified, long-biased growth vehicle.